Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 04 - 19    symbols : Snynf    save search

Sionna Therapeutics Launches with $111 Million Series B Financing to Advance Pipeline of Novel Small Molecules with the Potential to Fully Restore CFTR Function in Cystic Fibrosis
Published: 2022-04-19 (Crawled : 22:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%

fibrosis therapeutics potential cystic fibrosis
Ligand to Report First Quarter Financial Results on May 4
Published: 2022-04-19 (Crawled : 22:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%
LGND | $72.59 0.1% 0.1% 140K twitter stocktwits trandingview |
Health Technology
| | O: 0.87% H: 1.96% C: 1.58%

report results
Fueled by $111 Million, Sionna Therapeutics Takes Aim at Cystic Fibrosis
Published: 2022-04-19 (Crawled : 20:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%

fibrosis therapeutics cystic fibrosis
Oncomatryx Announces a €15 Million Capital Increase to Conduct Clinical Trials Against the Tumor Micro-environment
Published: 2022-04-19 (Crawled : 18:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%

trials trial
AUM Biosciences and HANDOK Presented Phase 1 Data for AUM-601 at ESMO Targeted Anticancer Therapies Congress 2022
Published: 2022-04-19 (Crawled : 15:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%

aum-601 phase 1 therapy
Cystic Fibrosis Foundation Invests $5 Million in Sionna Therapeutics to Develop New CFTR Modulator Therapy
Published: 2022-04-19 (Crawled : 14:20) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%

fibrosis therapeutics therapy cystic fibrosis
Gainers vs Losers
68% 32%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

KNW 4 | $0.59 -0.71% 18.64% 27K twitter stocktwits trandingview |
Manufacturing

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.